Generic immune complex assay for detection of murine anti-drug-antibodies in complex with human IgG
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Generic immune complex assay for detection of murine anti-drug-antibodies in complex with human IgG. / Boysen, Lykke; Sprinkel, Anne M.E.; Lauritzen, Brian; Breinholt, Jens; Lykkesfeldt, Jens; Viuff, Birgitte M.; Landsy, Lone H.
In: Biologicals, Vol. 60, 2019, p. 42-48.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Generic immune complex assay for detection of murine anti-drug-antibodies in complex with human IgG
AU - Boysen, Lykke
AU - Sprinkel, Anne M.E.
AU - Lauritzen, Brian
AU - Breinholt, Jens
AU - Lykkesfeldt, Jens
AU - Viuff, Birgitte M.
AU - Landsy, Lone H.
PY - 2019
Y1 - 2019
N2 - Rapid and versatile methods are needed for evaluation of immunogenicity in early safety studies. The present work presents a generic, simple and easy to use sandwich enzyme-linked immunosorbent assay for quasi-quantitative measurement of circulating immune complexes (CICs) formed by anti-drug antibodies (ADAs) in complex with human IgG in mouse plasma. The assay is suitable for evaluating the presence of in vivo formed CICs in mice exposed to human IgG antibodies independent of target and IgG subtype. The assay is established using commercially available antibodies, and calibrated using CIC mimics based on bis(sulfosuccinimidyl)suberate conjugated human and mouse IgG. The development and qualification process of the generic methodology is described and include acceptance criteria, stability, sensitivity, drug tolerance, spike recovery, precision and cut point determination. In order to demonstrate assay performance, its use is exemplified by quantifying CICs in mice administered with a fully human anti-TNF-α IgG1 antibody (adalimumab) or a humanized anti-trinitrophenol (TNP) IgG4 antibody. Results show a well-qualified reproducible assay set-up with adequate sensitivity, easy discrimination between positive and negatives and quasi-quantitative measurement of ADA-human IgG CICs in mice administered with each of two different human/humanized IgG antibodies.
AB - Rapid and versatile methods are needed for evaluation of immunogenicity in early safety studies. The present work presents a generic, simple and easy to use sandwich enzyme-linked immunosorbent assay for quasi-quantitative measurement of circulating immune complexes (CICs) formed by anti-drug antibodies (ADAs) in complex with human IgG in mouse plasma. The assay is suitable for evaluating the presence of in vivo formed CICs in mice exposed to human IgG antibodies independent of target and IgG subtype. The assay is established using commercially available antibodies, and calibrated using CIC mimics based on bis(sulfosuccinimidyl)suberate conjugated human and mouse IgG. The development and qualification process of the generic methodology is described and include acceptance criteria, stability, sensitivity, drug tolerance, spike recovery, precision and cut point determination. In order to demonstrate assay performance, its use is exemplified by quantifying CICs in mice administered with a fully human anti-TNF-α IgG1 antibody (adalimumab) or a humanized anti-trinitrophenol (TNP) IgG4 antibody. Results show a well-qualified reproducible assay set-up with adequate sensitivity, easy discrimination between positive and negatives and quasi-quantitative measurement of ADA-human IgG CICs in mice administered with each of two different human/humanized IgG antibodies.
KW - Anti-drug antibody (ADA)
KW - Circulating immune complex (CIC)
KW - Generic immunoassay
KW - Immunogenicity
U2 - 10.1016/j.biologicals.2019.05.008
DO - 10.1016/j.biologicals.2019.05.008
M3 - Journal article
C2 - 31200984
AN - SCOPUS:85066985442
VL - 60
SP - 42
EP - 48
JO - Biologicals
JF - Biologicals
SN - 1045-1056
ER -
ID: 236214512